New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays - PubMed (original) (raw)
. 2001 Nov 15;61(22):8235-40.
Affiliations
- PMID: 11719455
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays
P Kauraniemi et al. Cancer Res. 2001.
Abstract
Amplification of the ERBB2 oncogene at 17q12 has been well documented in breast cancer and has been shown to contribute to a poor clinical outcome. However, systematic surveys of copy number and expression levels of all genes within the 17q12 region have not been performed. Here, we used cDNA and comparative genomic hybridization microarray technologies to undertake a broad survey of genes involved in the 17q12 amplification in breast cancer. A chromosomal region-specific cDNA microarray containing 217 expressed sequence tag (EST) clones from 17q12 was constructed and used for parallel analysis of gene copy numbers and expression levels in seven breast cancer cell lines allowing direct identification of genes whose expression is elevated because of an increase in copy number in this chromosomal region. The copy number and expression survey identified 12 transcripts that showed a consistent pattern of increased copy number and expression in three or more of the 17q12-amplified cell lines. As expected, these included ERBB2 as well as the GRB7 and MLN64 genes previously shown to be coamplified with ERBB2. In addition, five other known genes and four uncharacterized ESTs were also found to be consistently activated by amplification in these breast cancer cell lines. Amplicon mapping by fluorescence in situ hybridization revealed a minimal common region of amplification containing four highly expressed genes, ERBB2, GRB7, MLN64, and an uncharacterized EST 48582. Furthermore, several other genes, although not located in the minimal common region of amplification, showed a correlated pattern of amplification and expression indicating that they might play a role in breast cancers with the 17q12 amplification. In conclusion, parallel analysis of gene copy number and expression levels by cDNA microarray can be used to directly identify candidate target genes involved in amplifications. Our results show that the 17q12 amplification in breast cancer leads to the simultaneous elevation of expression levels of several genes.
Similar articles
- RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
Kao J, Pollack JR. Kao J, et al. Genes Chromosomes Cancer. 2006 Aug;45(8):761-9. doi: 10.1002/gcc.20339. Genes Chromosomes Cancer. 2006. PMID: 16708353 - Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, van der Spek P, Henderson MA, Gish K, Venter DJ, Armes JE. Willis S, et al. Genes Chromosomes Cancer. 2003 Apr;36(4):382-92. doi: 10.1002/gcc.10138. Genes Chromosomes Cancer. 2003. PMID: 12619162 - Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
Dressman MA, Baras A, Malinowski R, Alvis LB, Kwon I, Walz TM, Polymeropoulos MH. Dressman MA, et al. Cancer Res. 2003 May 1;63(9):2194-9. Cancer Res. 2003. PMID: 12727839 - Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
Kauraniemi P, Kallioniemi A. Kauraniemi P, et al. Endocr Relat Cancer. 2006 Mar;13(1):39-49. doi: 10.1677/erc.1.01147. Endocr Relat Cancer. 2006. PMID: 16601278 Review. - National Oncology Forum: perspectives for the year 2000.
DeVita VT Jr, Bleickardt EW. DeVita VT Jr, et al. Cancer J. 2001 Jul-Aug;7 Suppl 1:S2-13. Cancer J. 2001. PMID: 11504281 Review.
Cited by
- Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients.
Hosny MM, Sabek NA, El-Abaseri TB, Hassan FM, Farrag SH. Hosny MM, et al. Int J Breast Cancer. 2016;2016:9545241. doi: 10.1155/2016/9545241. Epub 2016 Jun 20. Int J Breast Cancer. 2016. PMID: 27413552 Free PMC article. - Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.
Doi A, Ishikawa K, Shibata N, Ito E, Fujimoto J, Yamamoto M, Shiga H, Mochizuki H, Kawamura Y, Goshima N, Semba K, Watanabe S. Doi A, et al. Mol Oncol. 2015 Feb;9(2):355-64. doi: 10.1016/j.molonc.2014.09.005. Epub 2014 Sep 22. Mol Oncol. 2015. PMID: 25300573 Free PMC article. - The role of Neuregulin-1beta/ErbB signaling in the heart.
Pentassuglia L, Sawyer DB. Pentassuglia L, et al. Exp Cell Res. 2009 Feb 15;315(4):627-37. doi: 10.1016/j.yexcr.2008.08.015. Epub 2008 Sep 3. Exp Cell Res. 2009. PMID: 18801360 Free PMC article. Review. - Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD, Seachrist DD, Montañez-Wiscovich ME, Danielpour D, Keri RA. Landis MD, et al. Oncogene. 2005 Aug 4;24(33):5173-90. doi: 10.1038/sj.onc.1208712. Oncogene. 2005. PMID: 15897883 Free PMC article. - Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Nadler Y, González AM, Camp RL, Rimm DL, Kluger HM, Kluger Y. Nadler Y, et al. Ann Oncol. 2010 Mar;21(3):466-473. doi: 10.1093/annonc/mdp346. Epub 2009 Aug 28. Ann Oncol. 2010. PMID: 19717535 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous